EF
DGX icon

Empowered Funds’s Quest Diagnostics DGX Stock Holding History

Empowered Funds’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,155
Closed -$1.28M – 570
2022
Q4 		$1.28M Buy
+8,155
New +$1.17M 0.08% 231

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Empowered Funds's DGX Position: Q1 2026 in Review

Empowered Funds reduced its Quest Diagnostics (DGX) stake by 62% in Q1 2026, selling an estimated $2.99M and leaving 9,614 shares worth $1.88M. The position accounts for 0.01% of the portfolio, ranked #1138.

Empowered Funds first reported a position in DGX in Q4 2020 and has held it in 21 quarters since. The position peaked at $5.59M in Q4 2021. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Empowered Funds held 9,614 shares of Quest Diagnostics worth $1.88M as of Q1 2026.
  • Empowered Funds sold 15,381 Quest Diagnostics shares in Q1 2026, an estimated $2.99M.
  • Quest Diagnostics made up 0.01% of Empowered Funds's portfolio in Q1 2026, its #1138 holding.
  • Empowered Funds first reported a position in Quest Diagnostics in Q4 2020 and has held it in 21 quarters since.
  • Empowered Funds's Quest Diagnostics position peaked at $5.59M in Q4 2021.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.